$UAMY

Why is United States Antimony stock climbing today?

United States Antimony (UAMY) stock rose 1.9% in pre-market trading after the company's board approved a $100 million share repurchase program. This follows a Q2 revenue miss and lowered full-year guidance. Analyst Heiko Ihle reduced his price target to $9.25 but maintained a Buy rating. The broader market and critical minerals sector show mild support.

Original reporting
Published Aug 19, 2026, 12:35 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 19, 2026, 12:52 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$UAMY
Bullish
high confidence
Mentioned
$UAMY
Relevance
7/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$UAMYBullishHigh
01

Why it matters

The buyback announcement provides a fresh catalyst that may reverse the recent downtrend.

02

Market read

Primary corporate action for a micro‑cap, likely to generate short‑term buying interest.

03

What to watch

Pending Defense Logistics Agency contract deliveries and weak antimony prices remain execution risks.

Relevance 7/10Novelty 8/10Timing: pre‑open trading today

Background

UAMY reported Q2 revenue miss and cut full‑year guidance, prompting a price decline.

Company-level read

Ticker impact

$UAMYBullishHigh confidence
Context

Board approved a $100 million share repurchase program, disclosed in an 8‑K filing, driving a 1.9% pre‑open price rise.

Expected impact

Potential short‑term upside of 2‑4% as repurchases commence.

Evidence & confidence

Large $100 M buyback for a micro‑cap is material and newly disclosed, likely to attract buying pressure.

Market effects

Antimony and broader critical minerals sector may see modest support as peers consider similar buybacks.

U.S. small‑cap investors may reallocate into UAMY, marginally boosting the Russell 2000.

Limited to U.S. investors; no direct global macro effect.

Counterpoint

Buyback could be a defensive move masking deeper demand weakness for antimony.

Key entities

  • United States Antimony Corp.

    U.S. antimony producer (ticker UAMY).

  • Board of Directors

    Approved the $100 M share repurchase program.

Related articles

$UAMYMed

US Antimony (UAMY) Q2 2026 Earnings Call Transcript

US Antimony (UAMY) reported Q2 2026 revenue of $7.9M, down 25% YoY due to lower antimony prices but up 17% sequentially. Antimony revenue fell 39% YoY to $5.9M, while zeolite revenue surged 110% YoY to $1.9M. Gross profit declined to $0.6M from $2.8M YoY. The company has $62.2M in liquidity and is executing a $245M DLA contract. CEO Evans cited Chinese price manipulation for lower antimony prices.

$UAMYMedAI 8/10

UNITED STATES ANTIMONY CORP (UAMY): Results of Operations and Financial Condition

UNITED STATES ANTIMONY CORP (UAMY) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tm2622899d2_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Transcript of United States Antimony Corp. US Antimony Second Quarter 2026 Financial and Operational Results Webcast August 11, 2026 Participants Gary Evans - CEO & Chairman, United States Antimony Corporation Shawn Winkl